Good day and welcome to the Universal Technical Institute's Fourth Quarter and Full Year 2024 Earnings Call. All participants will be in listen-only mode. After today's presentation, there will be an opportunity to ask questions. Please note this event is being recorded. I would now like to turn the conference over to Matt Kempton, Vice President and Corporate Finance. Please go ahead.

Hello and welcome to Universal Technical Institute's fiscal fourth quarter and full year 2024 earnings call. Joining me today are our CEO, Jerome Grant; and Interim CFO, Christine Kline. Following our prepared remarks, we will open the call for your questions. A replay of this call, its transcript, and our investor presentation will be archived on the Investor Relations section of our website at investor.uti.edu along with our earnings release issued earlier today and furnished to the SEC. During this call, we may make comments that contain forward-looking statements as defined in the Private Securities and Litigation Reform Act of 1995, which by their nature address matters that are in the future and are uncertain. These statements reflect management's current beliefs and expectations and are subject to a number of factors that may cause actual results to differ materially from those statements. These factors include, but are not limited to those discussed in our earnings release and SEC filings. These statements do not guarantee future performance and therefore undue reliance should not be placed upon them. We do not intend to update these forward-looking statements as a result of new information or future developments, except as required by law. Please note, unless otherwise stated, all comparisons in this call will be against our results for the comparable period of fiscal 2023. The information presented today also includes non-GAAP financial measures. These should be viewed in addition to and not as a substitute for the company's reported results prepared in accordance with US GAAP. All non-GAAP financial measures referenced in today's call are reconciled in our earnings press release to the most directly comparable GAAP measure. For more information regarding definitions of our non-GAAP measures, please see our earnings release, financial supplement, and investor presentation. With that, I will turn the call over to Jerome Grant, CEO of Universal Technical Institute for his prepared remarks.

Thank you, Matt. Good afternoon, everyone. We had a very strong year that was in no small part motivated by our relentless dedication to building a future-ready workforce solutions provider and enhancing our program offerings to meet the demand in critical industries. As we continue to execute on our growth, diversification, and optimization strategy, we delivered improvements across all key metrics in our fiscal 2024 and continue to meet or exceed our expectations. For that accomplishment, I would like to take a moment to sincerely thank our divisional and corporate teams along with our partners and students for their exceptional efforts and their dedication to delivering strong results time and time again. Momentum continues to build as revenues for the fiscal year grew roughly 21% year-over-year to $733 million. Average full-time active students increased 10% year-over-year for the fiscal year. Net income increased to $42 million with diluted earnings per share of $0.75. Adjusted EBITDA improved an impressive 60% to $103 million. Total new student starts increased year-over-year by roughly 19% for the fiscal year. These start results exceeded the upper end of our guidance for the year and were driven by strong year-over-year start growth for both the Concorde and UTI divisions. Our ability to achieve this growth in 2024 was largely due to our ongoing commitment to three core expansion initiatives, which include the following. Number one, increasing the capacity of our current programs on campuses, such as adding dental hygiene operatories at Concorde and additional welding booths at UTI. Number two, adding programs from our current portfolio to more of our existing campus locations. Two great examples of this were the addition of the aviation program at Long Beach and HVACR at Avondale this past year. And Number three, launching brand new in-demand programs that we do not currently offer. In addition, we're focused on optimizing our workforce and facilities to support both future program and margin growth and to improve the efficiency of our operations. We also adjusted our marketing and admissions investments to accelerate lead generation and convert inquiries. Overall, we're proud of the meaningful growth we delivered across the board and our ability to consistently achieve or outperform our guidance. We're also pleased with the continued positive recognition for both our industry and company in national media outlets. For example, CNBC recently published two articles highlighting the increasing number of individuals who are choosing blue collar or what we call skilled collar jobs over traditional college paths. Both stories emphasize the financial stability and fulfilling careers these trades offer. This is a trend that appears to be accelerating in pace. Several of our UTI and Concorde graduates were featured in these articles, showcasing their success in our role as a vital resource for equipping students with the necessary skills to thrive in-demand industries. There is certainly a positive and growing sentiment for schools like UTI and Concorde across the macro environment. This demand for skilled collar workers and the promise of a balanced playing field for our industry in Washington combined with our excellent student outcomes gives us added confidence to reach our long-term targets. Turning to our division-specific highlights for 2024. Our Concorde division continues to deliver strong results with robust year-over-year growth. In the division's first full fiscal year under our ownership, Concorde has certainly surpassed our overall growth expectations. We saw strong growth across all Concorde's programs including clinical, core, and our new shorter cash pay programs as they continue to ramp. This growth is resulting from our increase in marketing investments throughout the year and the effectiveness of our admissions team. As far as Concorde's program expansion strategies, the Dallas Nursing Program capacity increase is still anticipated to begin in fiscal 2025. This effort will increase our capacity by an additional 60 students. Increasing the capacity of our Dental Hygiene Program in San Diego is also progressing well. And finally, our New Nursing Program in Jacksonville, Florida also remains on track to launch in mid-fiscal 2025. Turning now to partnerships. As we mentioned last quarter, we expanded Concorde's longstanding partnership with Heartland Dental with the plan to construct a new co-branded campus. This campus which will initially be launched on a non-Title IV cash pay basis will serve as a training center for dental assistants and dental hygienists and will feed directly into more than 1700 Heartland locations nationwide. When Concorde's growth restrictions are lifted, which is targeted for mid-2026, we will transition to also offering Title IV funding as well. This partnership not only helps satisfy the significant and increasing demand for trained dental hygienists and dental assistants, it also further optimizes our cost because Heartland is funding the construction of the campus, including initial supplies and durable equipment, as well as providing students with financial support. To reiterate, we anticipate this campus will add more than $4 million in run rate revenue, as well as contribute to Concorde's EBITDA margin expansion as it ramps. We look forward to keeping you updated as this partnership progresses and as we are able to launch additional campuses together over the next five years. Now on to our UTI division. The UTI division also continued to deliver consistent year-over-year growth driven by expanded programs and increasing market demand for skilled collar workers. Reflective of this market traction and our growth strategy, UTI generated a double-digit year-over-year revenue increase in 2024. UTI starts have steadily increased throughout the year and we expect this momentum to continue in 2025, with the first two large UTI starts in this new fiscal year performing quite well. Our HVACR programs continue to ramp nicely across campuses in Avondale, Long Beach and now Bloomfield with the program in Sacramento set to begin in the coming months pending regulatory approvals. The 14 programs we've launched in 2023 as part of synthesizing and expanding the MIT sourced aviation, skilled trades and energy programs across the UTI campuses are continuing to perform well. And the unification of the MIT Houston and UTI operations are on track to be finalized this quarter. As we previously stated, by mid-2025, our MIT Canton and Houston campuses, the Motorcycle Mechanics Institute, Marine Mechanics Institute and NASCAR Technical Institute campuses will all be known as UTI. These brand consolidations will help us enhance our operational efficiencies as well as leverage the renowned Universal Technical Institute name to further our outreach to potential students and industry partners. As part of our commitment to prepare graduates for industry with ever-changing technology requirements, we recently added our EV programs to our Avondale and Orlando campuses. These new courses are the same EV and hybrid training that are already available in our three California campuses. The enhanced curriculum is now part of the core automotive program on five UTI campuses with further rollouts planned. Additionally, with respect to our EV strategy, we updated our Ford FACT and BMW FastTrack manufacturer-specific advanced training program instances or MSATs to include the EV curriculum. All seven UTI campuses offering BMW FastTrack and all nine campuses offering the Ford FACT program are now teaching the new EV curriculum using the latest EV vehicles provided to us by BMW and Ford. Collectively, our relationships with both BMW and Ford are decades long. In fact, we recently celebrated 25 years of our Ford program, which graduated more than 29,000 students since its inception. Finally, underscoring our commitment to the highest standards of quality, I'd like to mention that both Dallas and Sacramento campuses were named Schools of Excellence by the Accrediting Commission of Career Schools and Colleges. This is ACCSC's highest honor and only 19 schools earned this award for the 2023-2024 accrediting period. These accolades reinforce our dedication to excellence in education and our positive impact on the communities we serve. Building on this great work being done by both of our divisions, I will now introduce our fiscal 2025 guidance which Christine will discuss in more detail in just a bit. Revenue is expected to be between $800 million and $815 million reflecting 10% year-over-year growth. We now anticipate adjusted EBITDA to be between $120 million and $124 million and we expect new student starts to range from 28,000 to 29,000. With fiscal 2024 now concluded, we are officially entering Phase Two of our multiyear North Star strategy. I'd like to take a moment to reiterate what this entails. Starting in fiscal 2025, we previously announced that we plan to launch a minimum of six new programs each year on Concorde and/or UTI campuses, subject to the required regulatory approvals. We also outlined our plan to open at least two new campuses annually beginning in fiscal 2026. To that point, I'm pleased to announce that we are finalizing our next three planned campus locations targeted for launch in 2026. One will be our first Concorde Heartland campus in Fort Myers, Florida. The second is a Skilled Trade and Aviation campus in Greenfield City. And the third will be an optimized UTI campus with a comprehensive set of program offerings in a state that is new to UTI. We are also happy to announce that we plan to launch nine full-length program expansions across our existing campus footprint and 10 cash pay short courses are lined up to launch on the Concorde campuses in 2025. We look forward to sharing more precise details on these campuses and programs in the very near future. We expect these initiatives will serve as the fuel for our previously announced compound annual revenue growth rate target of approximately 10% between 2024 and fiscal 2029, with an adjusted EBITDA margin for the company approaching 20% by the end of fiscal 2029 as our optimization efforts mature further. You can find more information on this strategy in our investor deck and on our website. We are also continuing to opportunistically evaluate and pursue strategic acquisitions. We would of course adjust these longer-term targets as appropriate if a transaction is completed. With that, I'll turn the call over to Christine Kline, our Interim CFO, to review our fiscal 2024 financials.

Thank you, Jerome. I'm pleased to share that we delivered another strong quarter and year meeting or exceeding our expectations across all guidance metrics for fiscal 2024. To summarize our operational performance, we recorded 26,885 total new student starts for fiscal 2024 exceeding our expectations, with 11,492 starts coming from the fourth quarter. As we've mentioned previously, Q4 is a seasonally high start quarter across both of our divisions and each delivered solid outcomes. In the fourth quarter, total average full-time active students grew 11% year-over-year, while total new student starts increased 10.6%. For the full year, average full-time active students increased 10% and new student starts increased 18.9% compared to the prior year. The year-over-year growth for both the quarter and full year were driven by increased yield from the tuning of our marketing and admission spend as well as new program expansion initiatives reaching steady state and strong contributions from Concorde. The Concorde division drove a 13.8% and 10.7% increase in average full-time active students for the fourth quarter and full year respectively. New student starts increased 13.7% in Q4 and 39.3% for the full year. These increases are a result of double-digit growth in shorter cash pay programs like sterile processing and phlebotomy as well as growth across core and clinical programs, which benefited from two large starts in Q4. The UTI division generated a 9.2% increase year-over-year in average full-time active students for the quarter and a 9.5% increase for fiscal 2024. New student starts grew 8.7% year-over-year in the fourth quarter and 6.7% for the full year. Notable contributions to this growth were the skilled collar programs added to UTI campuses in the current and prior year as well as the ongoing optimization of existing programs throughout our portfolio. Turning to our financial performance. Fourth quarter revenue on a consolidated basis increased 15.3% to $196.4 million. Concorde contributed $65.8 million, an increase of 19.7% over the prior year quarter, while the UTI division contributed $130.5 million, an increase of 13.2% over the prior year quarter. For the full year, consolidated revenue grew 20.6% to $732.7 million above the upper end of our guidance range. Concorde contributed $246.3 million, an increase of 38.3% over the prior year, while the UTI division contributed $486.4 million, representing a 13.3% increase over the prior year. Concorde benefited from the inclusion of two additional months of revenue during 2024 compared to 2023, given our December 1st, 2022 acquisition date. From a profitability standpoint, consolidated net income for the fourth quarter was $18.8 million or $0.34 per diluted share and $42 million or $0.75 per diluted share for the full year. Adjusted EBITDA for the fourth quarter was $37.3 million and $102.9 million for the full year. Both net income and EPS exceeded the upper end of our guidance range and adjusted EBITDA was in the middle of our projected range. At the end of the year, we had 53.8 million shares outstanding. Total available liquidity at the end of the quarter was $230.9 million, including $69 million of remaining capacity on our revolving credit facility. We also paid down an additional $11 million on our revolver in Q4 and ended the year with positive net working capital of $17 million. Note, as previously filed in an 8-K, in September, we increased the capacity of our revolving credit facility by $25 million to $125 million with an additional accordion feature, which provides us with greater financial flexibility as we lean into Phase Two of the North Star strategy in fiscal 2025. Fiscal 2024 operating cash flow was $85.9 million and adjusted free cash flow was $73.5 million, which significantly exceeded our full year guidance range of $62 million to $66 million due to outperformance of net income and lower capital spend than projected. Year-to-date capital expenditures were $24.3 million slightly below earlier projections for the year, primarily due to project timing and improved procurement savings. As we've previously stated, CapEx includes investments for our program expansion initiatives across both divisions as well as spending associated with curriculum and equipment refresh and upgrades, facility and leasehold improvements, and IT investments. Given our consistent execution throughout fiscal 2024 and in conjunction with our detailed organic growth strategy and the momentum we are carrying into this new year, we are confident in the formal guidance ranges we are providing for fiscal 2025. Starting with revenue. We expect to generate between $800 million and $815 million for fiscal 2025 or approximately 10% year-over-year growth at the midpoint. This reflects a strong increase in average full-time active students from the program additions across both divisions with total new student starts expected to range between 28,000 and 29,000. For the first quarter, we expect high-single to low-double-digit revenue growth with mid-single up to double-digit growth in the remaining quarters, with Q2 being the lowest growth period and Q4 expected to be the highest. For starts, we anticipate mid-single-digit start growth each quarter throughout the year, though Q2 should be somewhat higher. For fiscal 2025 net income, we expect a range of $52 million to $56 million and diluted earnings per share ranging between $0.93 to $1.01. Net income growth will be in the low to mid-double digits in the first two quarters with outsized growth coming in Q3 and Q4. We expect 2025 full year adjusted EBITDA to range between $120 million and $124 million or around a 19% year-over-year increase at the midpoint. We anticipate generating modest growth in the first quarter with double-digit increases each quarter thereafter and the largest growth in profitability occurring in the second half of the year. The increase is driven by the significant growth in revenue, optimized operations as well as the launch and maturity of additional programs in each division. An important item to highlight is that beginning in fiscal year 2025, we will start the first wave of growth investments for our new programs in campuses as Phase Two of our North Star strategy gets underway. Given the projected ongoing nature of these investments, we will no longer report them as one-time adjustments in our non-GAAP adjusted EBITDA calculation. We expect to incur approximately $8 million in growth investments related to our North Star strategy during fiscal 2025. We anticipate 2025 full year adjusted free cash flow to range between $58 million and $62 million, which assumes approximately $55 million in CapEx spend. This is reflective of the increasing growth investments required to fund incremental programs and campuses as part of our North Star roadmap. As with adjusted EBITDA, given the continuous and ongoing nature of these growth investments going forward, we will no longer report them as one-time adjustments for our non-GAAP and adjusted free cash flow calculation. We expect the bulk of our cash generation and year-over-year growth to materialize in the fourth quarter, consistent with our historical cadence. As always, in addition to this earnings call transcript, we encourage everyone to review our press release, financial supplement, and investor presentation as well as the 10-K once it is filed as these materials include the most current information on our consolidated and segment actual results, our strategic roadmap, and our guidance. Thank you to our students, team, partners, and investors for their ongoing support. I'll now turn the call back over to Jerome for closing remarks.

Thank you, Christine. The Universal Technical Institute and Concorde Career College divisions are both uniquely positioned and already have capitalized well on the increasing demand for skilled trades and health care education. Our results this past year demonstrate both the effectiveness and the successful conclusion of our first phase of our North Star strategy, which revolved around our core tenets of growth, diversification, and optimization. As we look ahead, we're excited to begin the next phase of our journey. Our focus remains on expanding our reach to meet growing student demands in new geographies, broadening the scope of our programs to include more high-demand fields and optimizing our operations to drive efficiency and enhance outcomes. Entering fiscal 2025, our organic initiatives continue to revolve around one, working towards expanding our campus footprint into greenfield geographies in a variety of ways, such as piloting our first skilled trades and aviation campus and launching an innovative co-branded campus. Two, broadening the reach of existing programs and a new in-demand offering. As noted in my earlier remarks, we have at least 19 more programs we are currently preparing to launch in 2025 across two divisions. And three, growing our partner network and deepening industry relationships as modeled by our co-branded Heartland campus. Inorganically, our efforts remain focused on opportunistically exploring strategic acquisition opportunities with an emphasis on enhancing our presence in health care with program offerings that will complement Concorde. Moving into our 60th year, the company stands stronger than ever. We're proud of our legacy and we're equally excited about the future. The need for skilled collar professionals is robust and growing. Our momentum is building and we are uniquely positioned to be a leader in training and supporting the next generation of skilled collar talent. With our consistent ability to meet or exceed expectations, a strong balance sheet, and a clear road map for growth, we are confident in our ability to deliver lasting value for our shareholders, students, and partners. 2024 was a strong year and 2025 will be a year marked by the readmission of our growth agenda. We appreciate your ongoing support and look forward to sharing more about our exciting progress in the quarters ahead. As always, we're happy to host campus tours and provide a closer look at the impactful initiatives we're pursuing. So please feel free to reach out if you'd like to visit. I'd now like to turn the call over to the operator for Q&A.

We will now begin the question-and-answer session. Our first question comes from Mike Grondahl with Northland Securities. Please go ahead.

Hey, guys. Congrats on a successful year. My first question just has to do, Jerome. You talked a little bit about macro tailwinds and those seem to have picked up. Is there any way you could kind of correlate the fall of '24 to the fall of '23 or the fall of '22 just so we can get a sense of the strength there? Hello?

Mike?

Yes.

Okay. You can hear us.

Your line is now unmuted sorry.

Thank you. I'm sorry. Our line was muted still. So I heard your question. So correlating '22, '23 and '24, if you remember back to '22, we had just come through that big spike in inflation in April of '22. And the fall of '22 was somewhat of a disaster really. I think enrollments were down double digits in the fall of '22. People were thinking very, very seriously about what they weren't going to invest in versus what they were. The recovery period that went all the way through '23 crescendoed in the fall of '23 and we started to see things pick up. I think back then, I was using the term, the new normal. People knew that gas was $4 a gallon and rent had gone up and they were starting to move on and think about where life would lead. As we moved into 2024, what we've seen, and we've seen it in our leads and our conversion rates and our enrollments throughout the year, as they continue to pick up is that we really are seeing people thinking about this area of the world, which is skilled collar workers, skilled trades workers as a viable profession and thinking more practically post high school about what they're going to do. I think you'll see that you saw the trends potentially if you saw labor statistics and some of the popular press out there that freshmen enrollments as a whole, meaning those students who are coming straight out of high school were down this fall, yet certificate and short programs were up. And I think we benefited from that in the fall of this year. Will it continue? I'm not an economist, but we are seeing a more favorable environment.

Got it. And then just a follow-up. You mentioned leads are up conversions up. You said you accelerated some investment in lead generation. Any update on the marketing funnel? It seems like you're having a lot of success there too.

We are seeing significant progress this year as we take the lead in transforming the Concorde Group from its previous state to its current position. We have increased our investment in Concorde's marketing and admissions teams to test the market's responsiveness, and the results have exceeded our expectations. The numbers we provided for Concorde were above what we anticipated. Consequently, we continued to increase our marketing expenditure throughout the year, adding additional funds in the fourth quarter to support our efforts in the first and second quarters. This additional investment was not part of our initial plan, but we are already observing positive outcomes, as I mentioned regarding both UTI and Concorde in the first quarter.

Got it. Thanks a lot.

And the next question comes from Eric Martinuzzi with Lake Street. Please go ahead.

Yes. The increase in the 2025 guidance, raising it from nearly $800 million to a midpoint of around $808 million, is that mainly due to the focused investments made at the end of FY'24, or is it driven by the ongoing implementation of the new programs you mentioned? What is the reason behind the positive adjustment for 2025?

Well, it's actually both, right, is that we are a bit more bullish on our ability to bring Concorde up further than initially in the year when we started looking at 2025. And then as you heard is that nine full-length programs and 10 short courses or short programs that we're bringing in exceeded the sort of minimum six that we had laid out for that. So if I were to cut the numbers in half, it's probably half and half. A few hundred more Concorde starts than we anticipated earlier in the year. We think we can drive and then the same out of those new programs.

Got you. Okay. And then I can definitely see a bump in your share price recently due to the results of the election. But what's your thinking on how quickly or maybe you don't think you benefit at all in the medium term here. But with the Republicans taking control here, is there a timeline in your mind for a potential benefit in the fundamentals of UTI?

Yes. Well, first of all, I'll say what I always say in these situations, which is we don't control what goes on in Washington. We control what goes on our 30 some campuses around the country. And we're going to continue to focus on superior outcomes, graduating around 70% of our kids, getting 80% to 90% of them jobs in the first year. The things that keep us above the fray of any of the view of Washington. Yes, there was a bump in the stock. I think sentiment out there is that with the rhetoric of potentially dismantling the Department of Education and the like. I think there was some sentiment that moved the stock in that direction. Generally speaking, what we're really looking for is something that we've been talking about for quite a while, which is I think we're moving into a phase where we'll see an even playing field, where the tax status of the educational institution isn't the primary issue, but the outcomes are. And if that shift in mindset materializes over the next year or so, we should continue to see favorable environment coming out of Washington.

Got it. Thank you for taking my questions.

Sure. Thanks.

And the next question comes from Raj Sharma with B. Riley. Please go ahead.

Thank you for answering my questions and congratulations on surpassing the fiscal '25 guidance. I would like to follow up on the earlier caller's comments regarding the Trump administration. Do you anticipate any changes in your SG&A expenses as a corporation? Will there be any adjustments in your lobbying efforts, or might they increase? Additionally, I know you have already addressed whether you expect fewer headwinds or regulatory oversight, but will the SG&A inquiry lead to higher expenses?

I'm not anticipating nor have I budgeted for a significant change in our SG&A associated with this. One of the dynamics there, Raj, is that when the Department of Education is in the hands of the Democratic Party there tends to be less action at the state level that goes on. And then when the Department of Education is in the hands of the Republican Party, there tends to be more action at the state level, especially the blue states, right? So California, Illinois, and New Jersey. And so it really just shifts the lobbying emphasis, I think, from central government to states.

Got it. And then any other potential areas to add? Are you looking at? I know that you had mentioned nursing in the past or to add at the Concorde. Any thoughts around that?

Well, we're continuing to look at program areas at Concorde. Yes, we have been talking about nursing. And in my comments, I said when we think about both organic and inorganic means, we are looking for programs that would complement what's already in the Allied Health and excuse me and dental focus that is at Concorde. And we're continuing to explore what might be there. The short course notion is born out of that. There is an opportunity for things like phlebotomy and sterile processing to have some quick certificate programs that get people out in the market working more quickly. We are looking at other health care areas that we may be able to enter whether it's home health or even veterinary and things along those lines, we're studying them. But we've got nothing planned for launches in 2025 outside of what's already on the docket.

Got it. And then on the fiscal '25 guidance, Jerome, the free cash flow guidance again seems sort of robust in the use of that cash earlier on, I think, are you still at the same plan of adding one new campus a year and a certain x next number of programs? Is that plan?

No. As I outlined in the comments, we're actually going to launch three campuses in 2026. The previously announced Concorde Heartland co-branded campus in Fort Myers. We have one skilled trades Aviation and Energy campus that's going to open. And candidly the only reason we didn't lay out cities yet is we like to get a lease sign in at least one or two of the regulatory hurdles, that's something that should happen in a matter of weeks, really. And therefore we'll be able to get locations out of those. And the way to look at it is our plan is to, on the UTI side, our plan is to basically open one campus every six months in '26. So one early in January and then one in the summer months to make sure that we're spreading out our work, our supply chain, our construction costs and things along those lines. And so we'll look at '27 soon. That's all we're going to do in '26, but what we've seen is pretty much equal opportunity on both the UTI and the Concorde side for opening campuses. And I think you can expect a pattern similar to what you see in '26 as we move forward.

And Raj this is Christine. I think I would just reiterate, we've said in previous calls that it takes about 18 months to turn a warehouse into a campus. So you think about that, the spend would certainly have to start in '25, which is where the $55 million in CapEx comes from.

Got it. And then just lastly on the starts guide. Is that you had pretty robust starts growth in '24, the '25 guide seems a little conservative. Is there any change in that or are you seeing any change that's making you do that or is that just part for the quarter?

We prefer not to overpromise at the outset. There is a noticeable transition between 2024 and 2025. In late 2023, we launched 14 full-length UTI programs and four Concorde programs among the top six. As these programs reach their peak in 2025 and achieve stable enrollment rates, we will likely see a reduction in the growth rates of the programs we initiated in 2023. In 2024, we introduced fewer programs. However, we are revitalizing the program launch in 2025, although most of those will not be available until mid to late in the year, leading to only a couple of hundred starts and less support from the previous year to drive growth in 2025. Growth will resume as we enter 2026, with three campuses and a similar number of programs expected to contribute that year.

Got it. Thank you so much for taking my questions. I'll take it offline. Thank you again.

Great.

Our next question comes from Jasper Bibb with Truist. Please go ahead.

Hey, good afternoon. I wanted to ask about the EBITDA margin guidance should we think about the margin expansion in fiscal '25 being fairly even across the UTI and Concorde segments or do you think the weighting of growth investments might shift that balance at all? Thank you.

So I think it's a great question. I think the margin expansion, you likely see a little stronger on the Concorde side because we're not investing as much in new campuses for Concorde. As you know the Heartland Campus is actually being funded by Heartland to move forward, whereas we're going to start spending on two campuses on the UTI side, take the capital expenditure out of the way. We'll likely start hiring some people late in 2025 as well. And so probably see slightly stronger uptake on the Concorde side. Also being now the second full year, we really started looking at where we could find margin expansion for Concorde as well. As we said, when we acquired them, they were at about an 8% EBITDA margin when we acquired them and we said we think we can get them to somewhere in the mid-teens within the first 36 months. Well, what you see in '25 is we're approaching that there already. And so we did a lot of hard work, and a lot of that is going to pay dividends also as we go through the year and into Q4 of next year.

Thanks. And then just wanted to confirm how many new program launches were in the fiscal '25 plans in the prepared remarks? And then I have a follow-up there.

So we've got nine what we would call full-length programs. And in the past, one of the things we've said is please look at the investor material. We've got some representation for sort of the average of what it costs to start one and what we get out of it, whether it's 150 to 200 students, et cetera, so that you can do some modeling around that. So we've got nine of those that we're launching, eight on the UTI side and one in Concorde. The one is the Jacksonville nursing program, which will launch sometime in the middle of this year. And then on top of that, we're moving more aggressively to proliferate the short courses across the non-Title IV short courses across the Concorde campuses. And again those are not big money, right? But I think one of the ways you want to look at those is we're tracking very closely the number of students that may come into a short course in sterile processing and then go on to take a surgical tech long program, right? So we really see it as a gateway to getting into the field, getting working and then taking longer courses. Phlebotomy, people come in and take a short phlebotomy and they move on to the metal assisting or vocational nursing program. And so it's a great way for people to dip their toe in the water in terms of health care. And what we're seeing is a significant portion that are now moving on into the longer courses. So it's going to help our recruiting efforts as well.

Right. I guess the nine is like a little bit higher than the, I guess, at least six that was in the North Star targets and you haven't really even kind of gotten into Concorde expansions with some of the restrictions there. So would you characterize this as an investment year as part of North Star or do you kind of view that six plus as a baseline and you potentially do quite a bit more than six annually if it depends there?

Well, this is the beginning of the investment to the next North Star plan. I think generally speaking, you can count on the similar number of programs at least six on the UTI side, pretty consistently over the period. And to your point, we haven't even gotten into because of the growth restrictions. We haven't even gotten into the Concorde programs, which likely wouldn't start launching until late '26 or into '27 right? And so from a program standpoint, I think you'll see a pretty even march from where we are in '25 into '26 and then we can accelerate in '27 and beyond when Concorde comes to the party. And the same as so on campus launches, right, is that we'll continue to focus on working with Heartland to get more of the dental hygiene dental assistant campuses up and running at their funding. But again, Concorde won't come to the game likely until '27 with any of their full-size campuses.

Makes sense. Thank you for taking the questions.

Our next question comes from Alex Paris with Barrington Research. Please go ahead.

Hi, guys. Thanks for taking my question. Most have been asked and answered, but I just had a couple of follow-ups. Marketing, it was increased and accelerated in the fourth quarter. I think your prepared comments said, just looking at the supplemental data, it was 9.3% of revenue in Q4 and 10.7% for the full year. Is this the new run rate or does it peak and kind of come down a little bit? What can you say about marketing and admissions costs which includes advertising going forward?

Well, we're continuing to get efficiencies, I think, out of our marketing and admission spend. And so as we get bigger, I think, you'll see that we get some leverage out of what we're doing. We're also getting leverage out of the fact that we're adding programs to the UTI campuses, right? So as we do local marketing for UTI, brand marketing in a market, now we have more opportunities to bring people into our campus in various areas, right? One of the things I think we've said in the past is we talked to about 0.5 million kids a year and even with starting 28,000 to 29,000. There still are significant numbers of them that are looking for more varied programs on the campuses and that will get us more starts at a lower cost because we're already gathering those leads. And so I think you'll continue to see some efficiency on marketing and admission spend going forward.

Great. That's helpful. Thank you. And then a couple of follow-ups on regulatory. I realize the election is a huge relief and win for the proprietary school industry. The idea of leveling a regulatory framework going forward, a level playing field as you put it. With regard to 90-10, I think 90-10 under the previous calculation in the UTI division was in the neighborhood of 67%. I'm wondering what percentage of UTI students are military or veteran?

About 15% of our students are from the military and veteran population. In the previous calculation, we were around 67%. When military funding transitions to federal funding, we end up around 82% or 83%, but it's actually 78%. We don't discuss this much because we're well under the radar, and it's a pass-fail assessment. I believe we won't reach any saturation point with the growth rates we're experiencing in nonmilitary adult and high school populations, so it’s not a concern.

Absolutely. 78% is a really good number under the new calculation. And that was legislation that was a law as opposed to regulatory. So I don't know that we'd have a lot of relief there under Trump at least in short order. But again that doesn't seem to be an issue for UTI either way. On the gainful employment side, gainful employment was effective on July 1st. There's been a couple of delays to October and January. There's a couple of lawsuits out there and there's a new administration in town. So this might be a moot point, but I'm just wondering, looking across the portfolio of programs. At both UTI and Concorde, were there any programs at risk if that regulation remains unchanged?

There is nothing at risk. There are a few programs at Concorde that are close to the line. For example, there are some small massage therapy programs with about 100 students combined, which are still compliant, but they are close to the line because tips are not considered part of the earnings. However, we do not have anything else that is even remotely near that situation.

That's great. I'll take my other questions offline. Thank you, Jerome.

Great. Hey, thanks a lot for the call.

This concludes our question-and-answer session. I would like to turn the conference back over to Jerome Grant for any closing remarks.

Thank you, operator. Well, first of all, I'd like to thank everyone for attending today. As always, Christine, Matt, and I will be available for follow-up questions over the next few days into next week. And we always look forward to speaking to our investors and analysts and we look forward once again to doing so in February when we share our first quarter results. So until then we'd all like to wish you all a very happy and healthy holiday season. Thanks a lot for calling in.

The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.